Neuromodulation Therapy

Nu-V3 Neuromodulation Therapy

Nu-V3 non-invasive neuromodulation therapy stimulates the peripheral auricular (ear) nerves through a safe, generated ‘pulsed’ micro-current signal with a device that is placed on the outside of the ear resulting in cranial nerve stimulation which in turn can help mitigate the symptoms of pain, anxiety, depression, and sleeplessness.

Nu-V3’s micro-signal sent to the cranial nerves of the Autonomic Nervous System (ANS), including the vagus nerve, assists it to regain the proper balance between the sympathetic and parasympathetic systems. This in turn also may result in:

Please note that Nu-V3 therapy is currently investigational and not FDA cleared and may become available in 2021.
To learn more, please visit Nu-V3.com.

Autonomic Nervous System Dysfunction

The Autonomic Nervous System (ANS) is comprised of the Parasympathetic and Sympathetic systems, which are typically in balance with one another. Pain, depression, anxiety, and sleeplessness create an imbalance between these systems. Nu-V3 helps to bring the ANS back into balance, from dysfunctional back to functional and provides significant relief of these symptoms.

Central Sensitization Syndrome

Central sensitization syndrome (CSS) is a condition that is associated with the development and maintenance of chronic pain. When central sensitization occurs, the nervous system goes through a process called “wind-up” and gets regulated in a persistent state of high reactivity and subsequently maintains pain even after an initial injury might be healed.

Antecedent factors can also play a role in the development of central sensitization. The onset of pain is often associated with subsequent development of conditions such as depression, insomnia, fear-avoidance, anxiety and other stressors. The stress of these responses can, in turn, further exacerbate the reactivity of the nervous system, leading to central sensitization.

Nu-V3 therapy can help “wind-down” the nervous and treat CSS.


Who specializes in offering Nu-V3 therapy at GCSP?

Currently Nu-V3 therapy may become available in 2021 and is only offered under the direction of Dr. Kamran Chaudhary. For more information or to see if you may qualify for treatment when available, please schedule a consultation with Dr. Chaudhary.

Patient Testimonials

Click on a video below to learn more about patient experiences with the Nu-V3 treatment and how it may change your life.